Medovex (NASDAQ: MDVX) this morning said it has received its first three commercial orders for its DenerveX™ System following the system’s CE mark approval earlier this month. The orders include both the DenerveX Kit containing the DenerveX Device and the DenerveX Pro-40 Generators for Germany, the UK and Italy. “Receiving multiple orders from three of our distributors so closely on the heels of our recent receipt of CE Mark clearly gives us reason for cautious optimism. We are pleased to be building atop of our recent accomplishment of receiving CE Mark, not just for our shareholders, but for all of those suffering from often debilitating lower back pain associated with Facet Joint Syndrome,” Medovex president and COO Patrick Kullmann stated in the news release.
To view the full press release, visit: http://nnw.fm/5Fg1I
Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The company’s first pipeline product, the DenerveX device, is intended to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options. To learn more about Medovex Corp., visit www.medovex.com.
NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer